XML 63 R53.htm IDEA: XBRL DOCUMENT v3.22.1
Financial Instruments - Information About Changes in Liabilities for Contingent Consideration (Details)
$ in Millions
3 Months Ended
Mar. 31, 2022
USD ($)
Mar. 31, 2021
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning balance $ 777 $ 841
Changes in estimated fair value (84) (13)
Payments (119) 0
Other (2) (12)
Fair value, ending balance 572 816
Current liability 149  
Contingent consideration 572 $ 816
Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Fair value, beginning balance 620  
Fair value, ending balance 439  
Contingent consideration $ 439  
Contingent consideration, measurement input, discount rate 0.115  
Measurement Input, Discount Rate | Sanofi Pasteur    
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]    
Contingent consideration, measurement input, discount rate 0.08